StonvexLoading…
StonvexCore line items from EXPE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.43B | $14.73B | $11.19B | $6.77B |
Operating Income | $251.00M | $1.87B | $1.45B | $415.00M |
Net Income | $-6.00M | $1.29B | $1.09B | $130.00M |
EPS (Diluted) | $-0.05 | $9.81 | $8.18 | $0.96 |
Total Assets | $26.46B | $24.45B | $25.11B | $26.98B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.54B | $5.41B | $5.83B | $6.30B |
Free Cash Flow OCF − CapEx | $3.75B | $3.11B | $2.99B | $3.68B |
Shares Outstanding | 114.48M | 116.97M | 117.51M | 118.97M |